Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators

被引:0
|
作者
Hauser, Robert G.
Hayes, David L.
Epstein, Andrew E.
Cannom, David S.
Vlay, Stephen C.
Song, Susan L.
Tyers, G. Frank O.
机构
[1] Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA
[2] Mayo Clin, Rochester, MN USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Good Samaritan Hosp, Los Angeles, CA USA
[5] Univ Hosp Stony Brook, Stony Brook, NY USA
[6] Univ So Calif, Los Angeles, CA USA
[7] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
关键词
implantable cardioverter-defibrillator; pulse generator; registry; complications;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Despite the widespread and growing use of implantable cardioverter-defibrillators (ICDs), little information is available regarding their performance or the impact of advanced pacing functions on ICD reliability and Longevity. OBJECTIVES The purpose of this study was to examine the performance of contemporary ICD pulse generators that failed or were replaced because of manufacturers recalls. METHODS ICD data were entered prospectively by nine participating centers. ICD pulse generator failure was defined as removal from service because the device was not functioning according to the manufacturer's specifications. A recalled ICD was a normally functioning pulse generator that was replaced as the result of a recall or advisory. RESULTS From 1998 to 2005, 1,220 ICDs failed and 135 were recalled and replaced. The average implant time of failed ICDs was 4.4 +/- 1.5 years and of recalled-ICDs was 1.7 +/- 0.8 years. The average implant time of single- and dual-chamber ICDs with rate responsive or cardiac resynchronization (CRT-D) pacing capabilities was significantly shorter than the average implant time of single- or dual-chamber devices without these features (P < .001). ICDs that provided rate responsive or CRT-D pacing failed earlier because of battery depletion (P < .001) and were significantly more prone to unexpected electronic or housing failure (9% vs 5%, P = .008) and recalls (25% vs 1%, P < .0001). Major adverse events included death (n = 2), failure to convert ventricular tachyarrhythmias (n = 6), and inappropriate shocks (n = 11). CONCLUSION Based on our analysis of failed and recalled devices, the performance of contemporary ICDs has been adversely affected by premature battery depletion, electronic failure, and manufacturers' recalls. Additional studies are needed to precisely estimate ICD longevity and to determine the incidence of unexpected ICD failure.
引用
收藏
页码:640 / 644
页数:5
相关论文
共 50 条
  • [31] Indications for implantable Cardioverter-Defibrillator
    Tebbenjohanns, J
    Niehaus, M
    Korte, T
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (41) : 2120 - 2124
  • [32] AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    EPSTEIN, AE
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1991, 102 (01): : 160 - 161
  • [33] The implantable cardioverter-defibrillator: An update
    Miller, Jared D.
    Yousuf, Omair
    Berger, Ronald D.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (07) : 606 - 611
  • [34] Implantable cardioverter-defibrillator utilization
    Camm, John
    EUROPACE, 2011, 13 (03): : 448 - 448
  • [35] Erosion of an Implantable Cardioverter-Defibrillator
    Elmouchi, Darryl
    Woelfel, Alan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (24) : E47 - E47
  • [36] Twiddling with an implantable cardioverter-defibrillator
    McCann, Conor J.
    Beelen, Roel
    Geelen, Peter
    ACTA CARDIOLOGICA, 2009, 64 (05) : 695 - 695
  • [37] Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
    Uslu, Abdulkadir
    Dogan, Cem
    Duman, Hakan
    Tanboga, Ibrahim Halil
    Askin, Lutfu
    Sevimli, Serdar
    NORTHERN CLINICS OF ISTANBUL, 2019, 6 (01) : 40 - 47
  • [38] Transvenous extraction of implantable cardioverter-defibrillator leads under advisory-A comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads
    Brunner, Michael P.
    Cronin, Edmond M.
    Jacob, Jessen
    Duarte, Valeria E.
    Tarakji, Khaldoun G.
    Martin, David O.
    Callahan, Thomas
    Borek, P. Peter
    Cantillon, Daniel J.
    Niebauer, Mark J.
    Saliba, Walid I.
    Kanj, Mohamed
    Wazni, Oussama
    Baranowski, Bryan
    Wilkoff, Bruce L.
    HEART RHYTHM, 2013, 10 (10) : 1444 - 1450
  • [39] Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing
    Welte, Nicolas
    Strik, Marc
    Eschalier, Romain
    Mondoly, Pierre
    Defaye, Pascal
    Frontera, Antonio
    Ritter, Philippe
    Haissaguerre, Michel
    Ploux, Sylvain
    Koneru, Jayanthi
    Ellenbogen, Kenneth A.
    Bordachar, Pierre
    HEART RHYTHM, 2017, 14 (07) : 1008 - 1015
  • [40] Performance of pacemaker and implantable cardioverter defibrillator pulse generators and leads: Results from the multicenter registry
    Hauser, R
    Hayes, D
    Cannom, D
    Parsonnet, V
    Furman, S
    Epstein, A
    Vlay, S
    Tyers, G
    Irwin, M
    Almquist, A
    Song, S
    Hayes, J
    Kallinen, L
    CLINICAL CARDIAC PACING AND ELECTROPHYSIOLOGY, 2003, : 173 - 179